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Abstract The Eps15 homology (EH) domain was originally
identified as a motif present in three copies at the NH2-termini of
Eps15 and of the related molecule Eps15R. Both of these
molecules are substrates for the tyrosine kinase activity of the
epidermal growth factor receptor and hence the name ‘Eps15
homology’ or EH domain [Wong et al. (1994) Oncogene 9, 1591^
1597; Wong et al. (1995) Proc. Natl. Acad. Sci. USA 92, 9530^
9534; Fazioli et al. (1993) Mol. Cell. Biol. 13, 5814^5828] was
derived. The motif was subsequently found in several proteins
from yeast to nematode, thus establishing its evolutionary
conservation. Initial studies with filter-binding assays and
phage-displayed libraries demonstrated its protein:protein inter-
action abilities and identified specific ligands. Subsequently,
structural analyses established the molecular bases of recognition
between EH domains and cognate peptides. To date, several EH-
containing and EH-binding proteins have been identified, which
establish in the cell a network of protein:protein interactions,
defined as the EH network. This network coordinates cellular
functions connected with endocytosis, actin remodeling and
intracellular transduction of signals. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
Key words: EH; Eps15; Endocytosis; Actin remodeling;
Signaling
1. The EH domain: de¢nition and binding speci¢city
The EH domain[1^3] is V100 amino acids long, and it is
present in proteins from Haemosporida Fungi, Plants, Nem-
atodes, Artropoda, Amphibia and Mammalia. We created a
pro¢le with a subset of EH domains from di¡erent species, by
employing domain boundaries according to the nuclear mag-
netic resonance (NMR) structure of the second EH domain of
human Eps15 [4]. This pro¢le was used to search all the public
protein databases, with the HMMER software [5]. After elim-
ination of redundancies, we identi¢ed 50 proteins containing
at least one EH domain. These proteins are listed in Table 1,
where they are identi¢ed with their EMBL/SwissProt acces-
sion numbers.
All non-redundant EH domains were aligned using the
Clustalw program. The alignment, shown in Fig. 1, was man-
ually adjusted and drawn using the ESPrit software [6]. Con-
served residues are identi¢ed according to amino acid phys-
ical^chemical properties, and they are colored in red when
present at a plurality of s 60%. The most conserved
(s 95%) residues are Leu45 and Trp49 in the alignment (cor-
responding to Leu165 and to Trp169 in the mEps15 protein).
They are indicated with a red arrow in Fig. 1.
A variety of approaches, from ¢lter-binding [3] to phage
display assays [7], were used to determine the binding abilities
of EH domains and identi¢ed three classes of binding pep-
tides. Phage display experiments [7] showed that the majority
of EH domains bind preferably to peptides containing an
NPF (asparagine^proline^phenylalanine) motif (class I pep-
tides). However binding to peptides containing FW (phenyl-
alanine^tryptophan), WW (tryptophan^tryptophan) or SWG
(serine^tryptophan^glycine) motifs (class II peptides) was also
found. A third class of ligands, containing a H(S/T)F (histi-
dine^serine/threonine^phenylalanine) motif, was found to
bind exclusively the EH1 of End3p. Consistent with these
¢ndings, the screening of a human ¢broblast expression li-
brary with the EH domains of Eps15 yielded several clones,
representing bona ¢de EH-binding proteins [8]. Among these
were Numb and Numbl [9], Hrb and Hrbl [10] and Epsin 1
[11]. These proteins displayed no sequence homology among
themselves except for the presence of one or more copies of
the NPF motif, which was in turn demonstrated to be indis-
pensable in vivo for the binding of the identi¢ed proteins to
the EH domains of Eps15 [8].
2. The EH domain: structure and molecular bases of
interaction
The structure of ¢ve di¡erent EH domains has been deter-
mined by NMR, including those of the EH1 of mouse Eps15
[12], the EH2 of human Eps15 [4], the EH3 of human Eps15
[13], the EH of POB1 [14] and the EH of Reps1 [15]. They
share the same fold, composed of two closely associated helix^
loop^helix motifs, also called EF-hands, connected by a short
antiparallel L-sheet (Fig. 2). EF-hands are endowed with
Ca2-binding properties [16]. All EH domains display two
EF-hand motif structures but not all of them possess all the
residues required for calcium-binding, as de¢ned by the can-
onical and the pseudo EF-hand consensus sequences [17,18].
Three of the ¢ve EH domains bind to calcium through their
second canonical EF-hand, formed by helices KC and KD,
because their ¢rst one does not contain the necessary residues
to coordinate the calcium ion. The EH3 of Eps15 binds to
Ca2 only through its ¢rst EF-hand, because in the second
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motif the residue at position 3 is a lysine instead of an aspar-
tate, a substitution that is predicted to repel a divalent cation.
The EH1 of Eps15 presents a pseudo (residues Gln25^Asp38)
and a canonical (residues Asp61^Glu72) EF-hand motif. How-
ever, both motifs di¡er in two critical residues with respect to
other EF-hand domains [17^19]. In the pseudo EF-hand con-
sensus, the residue at position 11 provides a side chain oxygen
ligand for metal-binding; in the EH1 of Eps15 this position is
occupied by a leucine (Leu35), which cannot perform this
function. In the canonical EF-hand consensus, the residue at
position 5 is usually an aspartate/asparagine, which provides a
side chain carbonyl for Ca2-binding. In the Eps15 EH1 do-
main, this residue is substituted by lysine (Lys65). Accordingly
the EH1 of Eps15 does not bind Ca2 at physiological con-
centrations, as predicted [12].
In all EH domains the binding pocket for the NPF motif is
made up by helices KB and KC (blue and yellow in Fig. 2). In
the EH2 of Eps15 Leu155, Leu165, and Trp169 form the bottom
Table 1
Accession numbers, domain composition and known interactors of EH-containing proteins
Name TREMBL/SwissProt
accession number
Organism Domains EH-binding proteins
EHD-RME-1 Q9N5B7 C. elegans 1 EH
EHD-PAST1 Q94919 Drosophila melanogaster 1 EH
EHD1 Q9UNR3 Homo sapiens COIL, 1 EH
EHD1-HPAST O14611 H. sapiens COIL, 1 EH
EHD2 Q9NZN4 H. sapiens COIL, 1 EH
EHD3 Q9NZN3 H. sapiens COIL, 1 EH
EHD4 Q9NZN2 H. sapiens 1 EH
EHD1 Q9WVK4 Mus musculus COIL, 1 EH
EHD3 Q9QXY6 M. musculus COIL, 1 EH
EHD4-MPAST2 Q9EQP2 M. musculus 1 EH
Q9W111 Q9W111 D. melanogaster 3 EH, COIL
END3 P39013 Saccharomyces cerevisiae 2 EH, COIL
PAN1 P32521 S. cerevisiae 2 EH, COIL Ent1p, Ent2p, Sla1p, yAP180A,
yAP180B
EDE1 P34216 S. cerevisiae 3 EH, COIL, UBA
O94685 O94685 Schizosaccharomyces pombe 3 EH, COIL, UBA
EHS-1 Q9BIF4 C. elegans 3 EH, COIL
EPS15 P42566 H. sapiens 3 EH, COIL Epsin, Hrb, Hrb1, Numb,
Numb1, synaptojanin
EPS15 P42567 M. musculus 3 EH, COIL Epsin, Hrb, Hrb1, Numb,
Numb1, synaptojanin
EPS15R Q9UBC2 H. sapiens 3 EH, COIL
EPS15R Q60902 M. musculus 3 EH, COIL Hrb, Hrb1
GAMMA-SYN Q9JKC9 Rattus norvegicus COIL, 1 EH SCAMP1
GAMMA-SYN Q9UMZ2 H. sapiens COIL, 1 EH
Intersectin-2 19NYG0 H. sapiens 2 EH, COIL, 5 SH3,
RhoGEF, PH, C2
Intersectin-2 19Z0R6 M. musculus 2 EH, COIL, 5 SH3,
RhoGEF, PH, C2
Epsin
Intersectin Q9U2T9 C. elegans 2 EH, COIL, 4 SH3 Hrb, Epsin
Intersectin-DAP160 Q9VIF7 D. melanogaster 2 EH, COIL, 5 SH3
Intersectin O95216 H. sapiens 2 EH, COIL, 5 SH3,
RhoGEF, PH, C2
Intersectin Q9Z0R4 M. musculus 2 EH, COIL, 5 SH3,
RhoGEF, PH, C2
Epsin
Intersectin Q9WVE9 R. norvegicus 2 EH, COIL, 5 SH3 SCAMP1
Intersectin O42287 Xenopus laevis 2 EH, COIL, 5 SH3 Hrb, Epsin
REPS1 Q9BXY9 H. sapiens 1 EH, COIL
REPS1 O54916 M. musculus 1 EH, COIL
POB1 O43428 H. sapiens 1 EH, COIL Eps15, Eps15R, Epsin
SAGA Q12076 Aspergillus nidulans 2 EH, COIL
Q9LM78 Q9LM78 Arabidopsis thaliana 2 EH, COIL
Q9LTR4 Q9LTR4 A. thaliana 1 EH
Q9XI16 Q9XI16 A. thaliana 2 EH, COIL
Q9NE15 Q9NE15 C. elegans 1 EH, COIL
Q9VKK0 Q9VKK0 D. melanogaster 1 EH, COIL
Q9H223 Q9H223 H. sapiens 1 EH
Q9H4M9 Q9H4M9 H. sapiens 1 EH
Q9NLB8 Q9NLB8 Plasmodium falciparum 1 EH
AAF99472 AAF99472 Plasmodium vivax 1 EH
O88638 O88638 R. norvegicus 1 EH
P36115 P36115 S. cerevisiae 1 EH, COIL
P47030 P47030 S. cerevisiae 1 EH
O14066 O14066 S. pombe 1 EH
Q10172 Q10172 S. pombe 2 EH, COIL, WH2
Q9HGL2 Q9HGL2 S. pombe 3 EH, COIL
Q9USZ7 Q9USZ7 S. pombe 2 EH
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Fig. 1. Multiple alignment of EH domains. Multiple alignments of all EH domains found in public protein databases with the HMMER soft-
ware. Amino acids are grouped according to physical^chemical properties : H/K/R, polar positive; D/E, polar negative; S/T/N/Q, polar neutral ;
A/V/L/I/M, non-polar aliphatic; F/Y/W, non-polar aromatic; P/G, small residues; C, cysteine (not groupable with other amino acids). Red col-
or is applied whenever group conservation exceeds 60%. Arrowheads on top of the alignment indicate the residues involved in the binding to
the peptide. Red arrows indicate residues whose mutation to Ala completely abolishes the EH:NPF binding. The blue arrow indicates the +3
position, with respect to the conserved Trp, that modulates the alternate binding speci¢city for NPF- or FW-containing peptides. The second-
ary structure of the second EH domain of hEps15 is reported at the bottom.
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of the pocket. The two latter residues are the most conserved
among all EH domains, and mutations at these positions are
incompatible with binding to NPF-containing peptides [4,7].
The NPF motif (class I peptides) binds to EH domains in a
type I Asn^Pro L-turn conformation, and is almost completely
buried in the binding pocket formed by helices KB and KC. A
type I L-turn conformation is also present in cyclized NPF
peptides and they have been shown to be better ligands than
the linearized counterparts [20]. The Phe residue in the peptide
serves as a central hydrophobic anchor. It is postulated [21]
that similar interactions underlie the binding of peptides of
other classes. This is supported by ¢ndings that FW and
NPF motifs bind in the same pocket of the EH3 of Eps15
[13]. Furthermore, all peptides selected by EH domains
have at least one aromatic amino acid, which could ¢t into
the binding pocket similarly to the Phe ring in the NPF motif
[21].
Four residues in the NPF-containing peptide mediate the
interaction with EH domains, i.e. the NPF itself and the res-
idue at position +3 with respect to Asn. This latter residue
seems important in determining binding a⁄nity. It contacts
several residues on the surface of the domain, and can stabi-
lize the L-turn conformation of the peptide [21]. On the other
hand, in the EH domain, the residue at position +3, with
respect to the conserved Trp, contributes to the speci¢city
of recognition of the cognate peptide. Domains that prefer
NPF have Ala or Ser at this position, while domains that
bind FW, WW or SWG display slightly larger amino acids
(Cys or Val). It has been shown that mutations (CysCAla/
Ser) in the third EH domain of Eps15, which binds preferably
FW, promote the binding to NPF peptides. Similarly, muta-
tions (AlaCVal/Cys) in the third EH domain of Eps15R,
which binds preferably NPF, promote the binding to FW
peptides [7]. However it was not possible to switch completely
the speci¢city of recognition from one class of peptides to
another [13].
Interestingly the EH3 of Eps15 can bind to a peptide re-
sembling the FW internalization motif of the mannose 6-phos-
phate receptor (MPR) [22], suggesting the possibility that
Eps15 could interact via its EH3 with the MPR in endosomes
and clathrin-uncoated vesicles where Eps15 is localized [23].
The EH domain of Reps1 can also bind, albeit with low
a⁄nity, to a peptide containing a DPF (aspartate^proline^
phenylalanine) motif [15]. This ¢nding supports the experi-
mental evidence that the EH domain of POB1 can bind di-
rectly to the C-terminus of Eps15, which contains 12 DPF
motifs [24], and that the ability of Eps15 to form tetramers
can be attributed to EH domain^DPF interactions [25]. DPF-
containing peptides were shown to constitute ligands for the
C-terminal appendage domain of K-adaptin [9,26]. The fact
that EH domains can also recognize DPF motifs suggests
interesting analogies. EH domains recognize the motif NPF
with a KD of approximately 500 WM [4], and the C-terminal
subdomain of K-adaptin domain recognizes the DPF motif
with similar a⁄nity [26]. Although there are no structural
similarities between these domains, the two binding sites pos-
sess some common features. Both of them are composed of a
hydrophobic pocket of similar size that has a tryptophan at
the base, and mutation of this residue to alanine abolishes
interaction with their binding counterpart. In both binding
sites, residues surrounding the tryptophan can provide specif-
icity for their binding targets [7,21,26].
Fig. 2. NMR structures of various EH domains. Known structures of EH domains. The domains represented here are those listed in red in
Fig. 1 (mEps15-EH1, PDB code 1qjt; hEps15-EH2 complexed with the NPF peptide of Hrb, in red, PDB code 1¡1; hEps15-EH3, PDB code
1c07; the EH domain of hPOB1, PDB code 1iq3; EH domain of mReps1, PDB code 1¢6). A violet sphere represents the calcium ion. The ¢g-
ures were prepared with the program MOLMOL [53].
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3. EH domain-containing proteins and their interactors: the
EH network
The biological functions of the EH network have recently
been reviewed in an extensive fashion [27]. Here we will brie£y
concentrate on more recent ¢ndings that further highlight the
involvement of this network in a variety of cellular processes.
When functional information is available, EH-containing
and EH-binding proteins are often implicated in the regula-
tion of protein transport/sorting and membrane tra⁄c (see
also [27]). For example, in mammals, Eps15 and Eps15R
are components of clathrin-coated pits. They also interact
with AP2, the major clathrin adaptor complex, and localize
to organelles of the endocytic route during receptor internal-
ization [23,28^30]. Accordingly, Eps15 was shown, by inter-
ference experiments, to be an essential component of the en-
docytic machinery [31^33]. Formal genetic evidence for an
involvement of the EH network in endocytosis was obtained
in yeast [34^38]. More recently, nematode studies provided
additional genetic evidence in higher eukaryotes. EHS-1, the
Caenorhabditis elegans homologue of Eps15, and RME-1, an-
other EH-containing protein, were, in fact, shown to be re-
quired for endocytic transport and synaptic vesicle recycling
[39,40]. A recent intriguing ¢nding concerns Numb, which is
an EH-binding protein associated to Eps15. Numb is a mem-
brane-associated protein that determines cell fate during both
nervous and muscle system development in £ies and mammals
[41^44]. Recently it was shown that mammalian Numb is an
endocytic protein [9] that is co-tra⁄cked with internalizing
receptors, interacts with AP2, and is involved in clathrin-
mediated endocytosis. These results raise the interesting pos-
sibility of participation of the endocytic machinery to cell fate
determination.
Regulation of actin cytoskeleton is another function linked
to EH-containing protein as demonstrated by yeast studies
[34,45], and, in mammals, by the interaction of two EH-con-
taining proteins, Reps1 and POB1, with RalBP1, a GTPase
activating protein for the CDC42 and Rac GTPases [46,47].
Recent studies of Intersectin further support this contention.
The so-called long isoform of Intersectin contains, in addition
to EH and SH3 domains, a DH-PH domain, a hallmark of
guanine exchange factors (GEFs) for Rho-GTPases. It was
shown that Intersectin can actually function as a GEF for
CDC42 [48]. In addition, N-WASP, a critical component of
the actin remodeling machinery, binds directly to Intersectin,
and upregulates its GEF activity. This, in turn, leads to the
production of GTP-bound CDC42, which is an activator of
N-WASP. Thus Intersectin participates in positive feedback
loops, leading to actin re-organization [48].
Evidence is also emerging that links directly EH-containing
and EH-binding proteins to intracellular signaling. Intersectin
was shown to bind to Sos1, a potent Ras-GEF, via its SH3
domains [49]. Accordingly, the SH3 domains of Intersectin
acted as dominant negative mutants on the activation of
Ras and mitogen-activated protein kinase (MAPK) [50]. Fur-
thermore, the overexpression of Intersectin activates the Elk-1
transcription factor, in a MAPK-independent manner. This
ability resides within the EH domains, as expression of the
tandem EH domains is su⁄cient to activate Elk-1 [51]. Finally
a role for endocytic proteins, including members of the EH
network, in the nucleus has been proposed. Eps15, Epsin,
CALM and AP2 accumulate in the nucleus when nuclear ex-
port is inhibited [52]. In the nucleus, Eps15 and CALM acted
as positive modulators of transcription in a GAL4-based
transactivation assay, suggesting that endocytic proteins par-
ticipate in the nucleus to transcriptional regulation [52].
4. Outlook
Originally thought to be exclusively involved in the regula-
tion of endocytosis, the network of EH-containing and EH-
binding proteins is now being implicated in a variety of other
cellular processes. Presently, the EH network extends its ram-
i¢cations from endocytosis to the control of the actin poly-
merizing machinery, to neurotransmission, to intracellular sig-
nal transduction, to cell fate determination, down to the
remote (from the endocytosis’ point of view) regions of the
nucleus, where a role in transcriptional regulation is sus-
pected. While a role in cancer is already emerging (reviewed
in [27]), the increasing connections with basic cellular process-
es predict further involvement of this protein network in hu-
man diseases.
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